Loading clinical trials...
Loading clinical trials...
A Phase 1, Randomized, Double-blind, Placebo-controlled, Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses and Multiple Doses of WVE-006 in Healthy Participants
Conditions
Interventions
WVE-006
Locations
1
United Kingdom
Simbec-Orion Clinical Pharmacology,
Merthyr Tydfil, Wales, United Kingdom
Start Date
November 14, 2023
Primary Completion Date
February 13, 2025
Completion Date
February 13, 2025
Last Updated
April 29, 2025
NCT00500123
NCT02796937
NCT02900183
NCT03815396
NCT03767829
NCT02001688
Lead Sponsor
Wave Life Sciences Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions